Younger contest enrolls 500 participants to test multi-clock biological age reversal over six months

The contest requires standard entrants to pay $999 for TruDiagnostic epigenetic profiling of 11 organ systems plus NeuroAge brain age scoring from cognitive tasks, grip strength metrics and Harvard facial age estimates from selfies. Ultra entrants pay $4,499 for additional blood panels, MRI and DEXA scans. Glorioso aims to build the largest public multi-clock dataset to clarify what individual clocks actually measure, addressing documented gaps in clock specificity noted in the 2023 Nature Reviews Molecular Cell Biology review of epigenetic clocks.

Existing single-clock studies, such as the Horvath clock validation across 51 tissues, show prediction errors exceeding five years in healthy adults, while multi-clock panels reduce variance by only 15-20 percent according to a 2024 eLife analysis of 12 commercial assays. Contest data collection under self-selected interventions like red-light therapy or sauna access will likely introduce selection bias and non-blinded outcomes, limiting causal inference on rejuvenation claims.

Operationally the dataset could accelerate validation thresholds for FDA biomarker qualification if raw methylation files are deposited in public repositories, yet it risks inflating consumer expectations for unproven longevity interventions without controlled endpoints.

Next steps include six-month endpoint analysis scheduled for April 2027, with leaderboard results published on NeuroAge's platform and potential follow-up trials targeting Alzheimer's risk prediction.